DENVER, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Elixinol, a wholly-owned subsidiary of Elixinol Global (ASX: EXL; OTCQX: ELLXF), achieved a milestone in the U.S. by reporting retail sales approaching seven figures over the Thanksgiving shopping holiday. The record revenue was buoyed by increased U.S. consumer demand and Elixinol’s annual U.S. “Buy One Get One” promotion over the U.S. Thanksgiving holiday shopping weekend.
The sales also equate to record-breaking donations to non-profit organizations at a time of year when most needed. 5% of all elixinol.com sales are donated to charity benefiting veterans and various health organizations.
“I co-founded this business with a global vision to give everyone, from individuals to organizations, the opportunity to enjoy hemp’s restorative benefits,” said Paul Benhaim, Elixinol Global CEO and Elixinol co-founder. “Our commitment to doing the right thing for the right reasons really shines this time of year,” he continued.
“A foundational value of Elixinol is ‘Do-Good, Feel-Good.’ The entire Elixinol team is proud of the charitable contributions to organizations important to our customers,” said Chris Husong, Elixinol Director of Marketing.
Besides industry-leading charitable donations, as one of the few CBD companies with complete seed-to-sale control, Elixinol has raised the standards for premium-grade CBD and hemp extracts. Elixinol provides customer assurances with transparent third-party potency and purity testing and food-grade extraction which meet or exceed the FDA’s Good Manufacturing Process (GMP) standards.
In addition to shoring up facilities, Elixinol spent 2018 hiring operational staff and increasing oversight with the promotion of Amberley Calvo, who is one of Elixinol’s original staff members. In her new position, as General Manager, Calvo oversees the operational systems and team members who make a milestone such as this possible.
“We knew this would be a record-setting year,” said Gabriel Ettenson, Elixinol co-founder and President.
“From seed-to-sale, we’ve been preparing for this all year long,” Ettenson continued.
Throughout 2018, Elixinol has been exceeding sales projections with triple-digit revenue growth.
The marketing, sales and customer service teams have also increased in 2018. Over the Black Friday-Cyber Monday holiday shopping weekend, Elixinol customer service agents answered over 500 online inquiries.
“It would be easy for Elixinol to cut corners on community support and even quality during such an incredible growth spurt, but instead, we’ve stayed true to ourselves and our community,” said Husong.
“It’s extremely rewarding to see those decisions benefiting everyone, including our nonprofits, in the Elixinol family,” Husong continued.
Colorado-based Elixinol, co-founded by Paul Benhaim, hemp entrepreneur since 1991, is widely regarded as one of the most influential CBD brands in the world. With a proven track record of growing and extracting premium-quality hemp, Elixinol is one of the few CBD hemp extract brands with complete seed-to-sale control over its products. Elixinol also conducts rigorous third-party laboratory testing and quality control. Elixinol distributes hemp-derived CBD products in 40 countries including North and South America, throughout Europe, Asia, and the Pacific Region under its own label and bulk CBD and wholesale CBD. Elixinol’s parent company EXL (elixinolglobal.com) is publicly traded on the Australian Securities Exchange and on the U.S. OTC (ASX:EXL, OTCQX: ELLXF). More information available at Elixinol.com.
+1 844-804-3504 ext 420